Dermorphin Analog is an analog of Dermorphin. Dermorphin is a natural heptapeptide μ-opioid receptor agonist found in amphibian skin.
CAT No: R1325
Dermorphin Analog is a synthetic peptide derivative structurally related to the naturally occurring opioid peptide dermorphin, which is known for its potent and selective agonist activity at the mu-opioid receptor. Characterized by modifications to the native dermorphin sequence, Dermorphin Analog exhibits unique receptor binding profiles and enhanced metabolic stability, making it a valuable tool for probing opioid receptor pharmacology. Its distinct biochemical properties have positioned it as a key compound in neuropharmacological research, molecular signaling studies, and the exploration of peptide-receptor interactions within the central nervous system.
Receptor Pharmacology: In the context of receptor pharmacology, Dermorphin Analog is frequently employed to investigate the binding characteristics, selectivity, and activation mechanisms of mu-opioid receptors. By using this analog in competitive binding assays and functional studies, researchers can elucidate differences in receptor affinity and efficacy compared to endogenous peptides or other synthetic ligands. Such investigations provide critical insights into the structure-activity relationships governing opioid receptor modulation and aid in the rational design of new receptor-targeted probes.
Neuroscience Research: The analog serves as a powerful tool for dissecting mu-opioid receptor signaling pathways in neuronal systems. Its high potency and selectivity enable precise modulation of receptor activity in in vitro and ex vivo preparations, facilitating studies of synaptic transmission, neuronal excitability, and downstream signaling cascades. These applications are particularly relevant for understanding the molecular basis of pain perception, reward mechanisms, and neuroadaptive processes associated with opioid exposure.
Peptide Structure-Activity Relationship Studies: Due to its modified amino acid sequence, Dermorphin Analog is instrumental in advancing structure-activity relationship (SAR) research within the peptide field. Scientists utilize the analog to systematically assess the impact of specific residue substitutions or backbone alterations on receptor interaction, metabolic stability, and functional activity. Such studies inform the optimization of peptide-based ligands for improved pharmacological profiles and contribute to the broader knowledge of peptide engineering.
Analytical Method Development: In analytical chemistry and bioanalytical method development, Dermorphin Analog is used as a reference standard or test analyte for validating detection methods such as liquid chromatography-mass spectrometry (LC-MS) or high-performance liquid chromatography (HPLC). Its defined structure and receptor activity profile make it a suitable compound for calibrating assays designed to quantify opioid peptides in biological samples or synthetic preparations, thereby supporting quality control and method validation efforts.
Peptide Synthesis Optimization: The compound also finds utility in the optimization of solid-phase peptide synthesis protocols. Researchers leverage Dermorphin Analog to evaluate coupling efficiency, sequence fidelity, and post-synthetic modifications during the assembly of complex peptide chains. Its well-characterized sequence and functional attributes provide a benchmark for troubleshooting synthetic challenges and refining peptide production workflows, which is essential for generating high-quality research peptides with consistent activity profiles.
1. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry
2. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
3. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum
5. Cationic cell-penetrating peptides are potent furin inhibitors
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More